Oncogenic K-Ras stimulates the expression of both AURKA and its activator,TPX2, as shown in pancreatic ductal adenocarcinomas (PDACs) cell lines KRASG12D mutated PANC-1 and KRASG12C mutated PaCa-2 [54]. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.